Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy

Journal of the Neurological Sciences

Volumn 290, Issue 1-2, 2010, Pages 131-134

  Triantafyllou, Nikos ^a   Lambrinoudaki, Irini ^b   Armeni, Elena ^b   Evangelopoulos, Eleftheria Maria ^a   Boufidou, Fotini ^a   Antoniou, Aris ^b   Tsivgoulis, Georgios ^c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Bone mineral density; Epilepsy; Valproate

Indexed keywords

CALCIFEDIOL; CALCIUM; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; VALPROIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; EPILEPSY; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MALE; MONOTHERAPY; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; ANTICONVULSANTS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; TIME; TIME FACTORS; VALPROIC ACID; YOUNG ADULT;

EID: 74849132390     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.12.015     Document Type: Article

References (19)

1. Valsamis H.A., Arora S.K., Labban B., and McFarlane S.I. Antiepileptic drugs and bone metabolism. Nutr Metab 3 (2006) 36
2. Pack A. Bone health in people with epilepsy: is it impaired and what are the risk factors?. Seizure 17 (2008) 181-186
3. Anderson G.D. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63 (2004) S3-S8
4. Heller A.J., Chestermen P., Elwes R.D.C., et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomized comparative monotherapy trial. J Neurol Neurosurg Psychiatry 58 (1995) 44-50
5. Sheth R.D., Wesolowski C.A., Jacob J.C., et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 127 (1995) 256-262
6. Akin R., Okutan V., Sarici Ü., et al. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 19 (1998) 129-131
7. Pavlakis S.G., Chusid R.C., Roye D.P., et al. Valproate therapy: predisposition to bone fracture?. Pediatr Neurol 19 (1998) 143-144
8. Kafali G., Erselcan T., and Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr 38 (1999) 93-98
9. Sato Y., Kondo I., Ishida S., et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57 (2001) 445-449
10. Farhat G., Yamout B., Mikati M.A., et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58 (2002) 1348-1353
11. Boluk A., Guzelipek M., Savli H., Temel I., Ozişik H.I., and Kaygusuz A. The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 50 (2004) 93-97
12. Pack A.M., Morrell M.J., Randall A., McMahon D.J., and Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70 (2008) 1586-1593
13. Kim S.H., Lee J.W., Choi K.G., Chung H.W., and Lee H.W. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 10 (2007) 291-295
14. Kanis J.A., Melton L.J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 9 (1994) 1137-1141
15. Lukert B.P., and Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112 (1990) 352-364
16. Pack A.M., Morrell M.J., Marcus R., et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57 (2005) 252-257
17. Davie M.W., Emberson C.E., Lawson D.E., et al. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. Q J Med 52 (1983) 79-91
18. Gough H., Goggin T., Bissessar A., Baker M., Crowley M., and Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 59 (1986) 569-577
19. Stephen L.J., McLellan A.R., Harrison J.H., et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 8 (1999) 339-342